PEGylation of the antimicrobial peptide LyeTx I-b maintains structure-related biological properties and improves selectivity

The biological activity of antimicrobial peptides and proteins is closely related to their structural aspects and is sensitive to certain post-translational modifications such as glycosylation, lipidation and PEGylation. However, PEGylation of protein and peptide drugs has expanded in recent years d...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in molecular biosciences Vol. 9; p. 1001508
Main Authors Moreira Brito, Júlio César, Carvalho, Lucas Raposo, Neves de Souza, Amanda, Carneiro, Guilherme, Magalhães, Paula Prazeres, Farias, Luiz Macêdo, Guimarães, Natália Rocha, Verly, Rodrigo Moreira, Resende, Jarbas Magalhães, Elena de Lima, Maria
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 13.10.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The biological activity of antimicrobial peptides and proteins is closely related to their structural aspects and is sensitive to certain post-translational modifications such as glycosylation, lipidation and PEGylation. However, PEGylation of protein and peptide drugs has expanded in recent years due to the reduction of their toxicity. Due to their size, the PEGylation process can either preserve or compromise the overall structure of these biopolymers and their biological properties. The antimicrobial peptide LyeTx I-b was synthesized by Fmoc strategy and coupled to polyethylene glycol 2.0 kDa. The conjugates were purified by HPLC and characterized by MALDI-ToF-MS analysis. Microbiological assays with LyeTx I-b and LyeTx I-bPEG were performed against (ATCC 33591) and (ATCC 25922) in liquid medium. MIC values of 2.0 and 1.0 µM for LyeTx I-b and 8.0 and 4.0 µM for LyeTx I-bPEG were observed against and , respectively. PEGylation of LyeTx I-b (LyeTx I-bPEG) decreased the cytotoxicity determined by MTT method for VERO cells compared to the non-PEGylated peptide. In addition, structural and biophysical studies were performed to evaluate the effects of PEGylation on the nature of peptide-membrane interactions. Surface Plasmon Resonance experiments showed that LyeTx I-b binds to anionic membranes with an association constant twice higher than the PEGylated form. The three-dimensional NMR structures of LyeTx I-b and LyeTx I-bPEG were determined and compared with the LyeTx I-b structure, and the hydrodynamic diameter and zeta potential of POPC:POPG vesicles were similar upon the addition of both peptides. The mPEG-MAL conjugation of LyeTx I-b gave epimers, and it, together with LyeTx I-bPEG, showed clear α-helical profiles. While LyeTx I-b showed no significant change in amphipathicity compared to LyeTx I-b, LyeTx I-bPEG was found to have a slightly less clear separation between hydrophilic and hydrophobic faces. However, the similar conformational freedom of LyeTx I-b and LyeTx I-bPEG suggests that PEGylation does not cause significant structural changes. Overall, our structural and biophysical studies indicate that the PEGylation does not alter the mode of peptide interaction and maintains antimicrobial activity while minimizing tissue toxicity, which confirmed previous results obtained . Interestingly, significantly improved proteolytic resistance to trypsin and proteinase K was observed after PEGylation.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by: Luca Domenico D'Andrea, National Research Council (CNR), Italy
Marco Sette, University of Rome Tor Vergata, Italy
ORCID: Lucas Raposo Carvalho, orcid.org/0000-0002-6476-4531; Maria Elena de Lima, orcid.org/0000-0001-6185-4032
These authors have contributed equally to this work and share first authorship
This article was submitted to Cellular Biochemistry, a section of the journal Frontiers in Molecular Biosciences
Reviewed by: Elizabeth Kelley, National Institute of Standards and Technology, United States
ISSN:2296-889X
2296-889X
DOI:10.3389/fmolb.2022.1001508